Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 6, 2009 - Issue 5
Submit an article Journal homepage
624
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Tight junction modulator and drug delivery

Koji Matsuhisa Osaka University, Graduate School of Pharmaceutical Sciences, Department of Bio Functional Molecular Chemistry, Suita, Osaka 565-0871, Japan +81 6 6879 8196; +81 6 6879 8199; [email protected]
,
Masuo Kondoh Osaka University, Graduate School of Pharmaceutical Sciences, Department of Bio Functional Molecular Chemistry, Suita, Osaka 565-0871, Japan +81 6 6879 8196; +81 6 6879 8199; [email protected]
,
Azusa Takahashi Osaka University, Graduate School of Pharmaceutical Sciences, Department of Bio Functional Molecular Chemistry, Suita, Osaka 565-0871, Japan +81 6 6879 8196; +81 6 6879 8199; [email protected]
&
Kiyohito Yagi Osaka University, Graduate School of Pharmaceutical Sciences, Department of Bio Functional Molecular Chemistry, Suita, Osaka 565-0871, Japan +81 6 6879 8196; +81 6 6879 8199; [email protected]
Pages 509-515 | Published online: 12 May 2009

Bibliography

  • Majumdar S, Duvvuri S, Mitra AK. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development. Adv Drug Deliv Rev 2004;56:1437-52
  • Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol Rev 2003;55:425-61
  • Inui KI, Masuda S, Saito H. Cellular and molecular aspects of drug transport in the kidney. Kidney Int 2000;58:944-58
  • Koepsell H. Organic cation transporters in intestine, kidney, liver, and brain. Annu Rev Physiol 1998;60:243-66
  • Meijer DK, Hooiveld GJ, Schinkel AH, et al. Transport mechanisms for cationic drugs and proteins in kidney, liver and intestine: implication for drug interactions and cell-specific drug delivery. Nephrol Dial Transplant 1999;4(Suppl 14):1-3
  • Van Aubel RA, Masereeuw R, Russel FG. Molecular pharmacology of renal organic anion transporters. Am J Physiol Renal Physiol 2000;279:F216-32
  • Anderson JM, Van Itallic CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 1995;269:G467-75
  • Powell DW. Barrier function of epithelia. Am J Physiol 1981;241:G275-88
  • Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993;123:1777-88
  • Furuse M, Fujita K, Hiiragi T, et al. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 1998;141:1539-50
  • Furuse M, Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol 2006;16(4):181-8
  • Wong V, Gumbiner BM. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 1997;136(2):399-409
  • Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol 2006;68:403-29
  • Morita K, Furuse M, Fujimoto K, Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 1999;96:511-6
  • Furuse M, Hata M, Furuse K, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002;156:1099-111
  • Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003;161:653-60
  • Sonoda N, Furuse M, Sasaki H, et al. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999;147:195-204
  • Kondoh M, Masuyama A, Takahashi A, et al. A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol Pharmacol 2005;67:749-56
  • Takahashi A, Komiya E, Kakutani H, et al. Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of Clostridium perfringens enterotoxin, by site-directed mutagenesis. Biochem Pharmacol 2008;75:1639-48
  • Takahashi A, Kondoh M, Masuyama A, et al. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4. J Control Release 2005;108:56-62
  • Van Itallie CM, Betts L, Smedley JG III, et al. Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J Biol Chem 2008;283:268-74
  • Ling J, Liao H, Clark R, et al. Structural constraints for the binding of short peptides to claudin-4 revealed by surface plasmon resonance. J Biol Chem 2008;283:30585-95
  • Mrsny RJ, Brown GT, Gerner-smidt K, et al. A key claudin extracellular loop domain is crucial for epithelial barrier integrity. Am J Pathol 2008;172:905-15
  • Furuse M, Sasaki H, Tsukita S. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 1999;147:891-903
  • Wong CH, Mruk DD, Lee WM, Cheng CY. Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate. FASEB J 2007;21:438-48
  • Madeley CR, Cosgrove BP. Letter: 28 nm particles in faeces in infantile gastroenteritis. Lancet 1975;2:451-2
  • Moser LA, Carter M, Schultz Cherry S. Astrovirus increases epithelial barrier permeability independently of viral replication. J Virol 2007;81:11937-45
  • Monteleone G, Fina D, Caruso R, Pallone F. New mediators of immunity and inflammation in inflammatory bowel disease. Curr Opin Gastroenterol 2006;22(4):361-4
  • Al Sadi RM, Ma TY. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 2007;178:4641-9
  • Al Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol 2008;180:5653-61
  • Tanaka M, Kamata R, Sakai R. EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability. J Biol Chem 2005;280:42375-82
  • Larson J, Schomberg S, Schroeder W, Carpenter TC. Endothelial EphA receptor stimulation increases lung vascular permeability. Am J Physiol 2008;295:L431-9
  • Aasheim HC, Pedeutour F, Grosgeorge J, Logtenberg T. Cloning, chromosal mapping, and tissue expression of the gene encoding the human Eph-family kinase ligand ephrin-A2. Biochem Biophys Res Commun 1998;252:378-82
  • Salama NN, Eddington ND, Fasano A. Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev 2006;58:15-28
  • Fasano A, Uzzau S. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J Clin Invest 1997;99:1158-64
  • Fasano A, Uzzau S, Fiore C, Margaretten K. The enterotoxic effect of Zonula occludens toxin on rabbit small intestine involves the paracellular pathway. Gastroenterology 1997;112:839-46
  • Fasano A, Baudry B, Pumplin DW, et al. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci USA 1991;88:5242-6
  • Fasano A, Fiorentini C, Donelli G, et al. Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J Clin Invest 1995;96:710-20
  • Cox DS, Gao H, Raje S, et al. Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin. Eur J Pharm Biopharm 2001;52:145-50
  • Cox DS, Raje S, Gao H, et al. Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin. Pharm Res 2002;19:1680-8
  • Lee A, White N, Van der Walle CF. The intestinal zonula occludens toxin (ZOT) receptor recognises non-native ZOT conformers and localises to the intercellular contacts. FEBS Lett 2003;555:638-42
  • Di Pierro M, Lu R, Uzzau S, et al. Zonula occludens toxin structure-function analysis. Identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J Biol Chem 2001;276:19160-5
  • Song KH, Fasano A, Eddington ND. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A. Int J Pharm 2008;351:8-14
  • Thanou M, Verhoef JC, Junginger HE. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev 2001;50(Suppl 1):S91-101
  • Kotze AF, Luessen HL, De leeuw BJ, et al. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release 1998;51:35-46
  • Lee DW, Baney RH. Oligochitosan derivatives bearing electron-deficient aromatic rings for adsorption of amitriptyline: implications for drug detoxification. Biomacromolecules 2004;5:1310-5
  • Smith JM, Dornish M, Wood EJ. Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption. Biomaterials 2005;26:3269-76
  • Lin YH, Mi FL, Chen CT, et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 2007;8:146-52
  • Matsumura T, Jin Y, Kabumoto Y, et al. The HA proteins of Botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell Microbiol 2008;10:355-64
  • Boven LA, Middel J, Verhoef J, et al. Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia. Neuropathol Appl Neurobiol 2000;26:356-60
  • Dallasta LM, Pisarov LA, Esplen JE, et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999;155:1915-27
  • Persidsky Y, Heilman D, Haorah J, et al. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood 2006;107:4770-80
  • Zhong Y, Smart EJ, Weksler B, et al. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci 2008;28:7788-96
  • Annunziata P. Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism. J Neurol 2003;250:901-6
  • Dhillon NK, Peng F, Bokhari S, et al. Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2/CCR2 axis across the blood-brain barrier: implications for HIV-dementia. J Neuroimmune Pharmacol 2008;3:52-6
  • Zhang L, Looney D, Taub D, et al. Cocaine opens the blood-brain barrier to HIV-1 invasion. J Neurovirol 1998;4:619-26
  • Preston E, Slinn J, Vinokourov I, Stanimirovic D. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate. J Neurosci Methods 2008;168:443-9
  • Yamauchi A, Dohgu S, Nishioku T, et al. An inhibitory role of nitric oxide in the dynamic regulation of the blood-brain barrier function. Cell Mol Neurobiol 2007;27:263-70
  • Fiorini C, Tilloy Ellul A, Chevalier S, et al. Sertoli cell junctional proteins as early targets for different classes of reproductive toxicants. Reprod Toxicol 2004;18:413-21
  • Zhang YH, Lin L, Liu ZW, et al. Disruption effects of monophthalate exposures on inter-Sertoli tight junction in a two-compartment culture model. Environ Toxicol 2008;23:302-8
  • Xia W, Mruk DD, Cheng CY. C-type natriuretic peptide regulates blood-testis barrier dynamics in adult rat testes. Proc Natl Acad Sci USA 2007;104:3841-6
  • Potter LR, Abbey Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006;27:47-72
  • Gnessi L, Fabbri A, Spera G. Gonadal peptides as mediators of development and functional control of the testis: an integrated system with hormones and local environment. Endocr Rev 1997;18:541-609
  • Yan HH, Mruk DD, Wong EW, et al. An autocrine axis in the testis that coordinates spermiation and blood-testis barrier restructuring during spermatogenesis. Proc Natl Acad Sci USA 2008;105:8950-5
  • Song KH, Fasano A, Eddington ND. Enhanced nasal absorption of hydrophilic markers after dosing with AT1002, a tight junction modulator. Eur J Pharm Biopharm 2008;69:231-7
  • Seki T, Kanbayashi H, Chono S, et al. Effects of a sperminated gelatin on the nasal absorption of insulin. Int J Pharm 2007;338:213-8
  • Seki T, Kanbayashi H, Nagao T, et al. Effect of aminated gelatin on the nasal absorption of insulin in rats. Biol Pharm Bull 2005;28:510-4
  • Lowman HB. Bacteriophage display and discovery of peptide leads for drug development. Annu Rev Biophys Biomol Struct 1997;26:401-24
  • Sidhu SS. Phage display in pharmaceutical biotechnology. Curr Opin Biotechnol 2000;11:610-6
  • Herman RE, Makienko EG, Prieve MG, et al. Phage display screening of epithelial cell monolayers treated with EGTA: identification of peptide FDFWITP that modulates tight junction activity. J Biomol Screen 2007;12:1092-101
  • Ikenouchi J, Furuse M, Furuse K, et al. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005;171:939-45
  • Lee DBN, Jamgotchian N, Allen SG, et al. A lipid-protein hybrid model for tight junction. Am J Physiol 2008;295:F1601-12
  • Chen-Quay SC, Eting KT, Li awa, et al. Identification of tight junction modulating lipids. J Pharm Sci 2009;98:606-19
  • Sugibayashi K, Onuki Y, Takayama K. Displacement of tight junction proteins from detergent-resistant membrane domains by treatment with sodium caprate. Eur J Pharm Sci 2009;36:246-53

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.